{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:15:18Z","timestamp":1790360118518,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T00:00:00Z","timestamp":1585008000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T00:00:00Z","timestamp":1585008000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"DIM analytics from the R\u00e9gion Ile de France","award":["MOBICS"],"award-info":[{"award-number":["MOBICS"]}]},{"DOI":"10.13039\/501100001665","name":"French national Research Agency","doi-asserted-by":"crossref","award":["ANR-11-IDEX-0003-02"],"award-info":[{"award-number":["ANR-11-IDEX-0003-02"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anal Bioanal Chem"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s00216-020-02560-5","type":"journal-article","created":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T16:04:07Z","timestamp":1585065847000},"page":"3103-3111","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Evidence for different in vitro oligomerization behaviors of synthetic hIAPP obtained from different sources"],"prefix":"10.1007","volume":"412","author":[{"given":"Corentin","family":"Berardet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Kaffy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Halgand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Van der Rest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Ongeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Taverna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,24]]},"reference":[{"key":"2560_CR1","unstructured":"WHO (2019) Diabetes. https:\/\/www.who.int\/health-topics\/diabetes. Accessed 6 Oct 2019."},{"key":"2560_CR2","doi-asserted-by":"publisher","first-page":"826706","DOI":"10.1155\/2013\/826706","volume":"2013","author":"K Pillay","year":"2013","unstructured":"Pillay K, Govender P. Amylin uncovered: a review on the polypeptide responsible for type II diabetes. Biomed Res Int. 2013;2013:826706. https:\/\/doi.org\/10.1155\/2013\/826706.","journal-title":"Biomed Res Int"},{"key":"2560_CR3","doi-asserted-by":"publisher","first-page":"4998","DOI":"10.1046\/j.1432-1327.2000.01548.x","volume":"267","author":"CE Higham","year":"2000","unstructured":"Higham CE, Hull RL, Lawrie L, Shennan KI, Morris JF, Birch NP, et al. Processing of synthetic pro-islet amyloid polypeptide (proIAPP) \u201camylin\u201d by recombinant prohormone convertase enzymes, PC2 and PC3, in vitro. Eur J Biochem. 2000;267:4998\u20135004.","journal-title":"Eur J Biochem"},{"key":"2560_CR4","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1210\/er.2007-0037","volume":"29","author":"L Haataja","year":"2008","unstructured":"Haataja L, Gurlo T, Huang CJ, Butler PC. Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis. Endocr Rev. 2008;29:303\u201316. https:\/\/doi.org\/10.1210\/er.2007-0037.","journal-title":"Endocr Rev"},{"key":"2560_CR5","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.2147\/CIA.S95297","volume":"10","author":"HR Jeong","year":"2015","unstructured":"Jeong HR, An SS. Causative factors for formation of toxic islet amyloid polypeptide oligomer in type 2 diabetes mellitus. Clin Interv Aging. 2015;10:1873\u20139. https:\/\/doi.org\/10.2147\/CIA.S95297.","journal-title":"Clin Interv Aging"},{"key":"2560_CR6","doi-asserted-by":"publisher","first-page":"515307","DOI":"10.1155\/2015\/515307","volume":"2015","author":"PT Nguyen","year":"2015","unstructured":"Nguyen PT, Andraka N, De Carufel CA, Bourgault S. Mechanistic contributions of biological cofactors in islet amyloid polypeptide amyloidogenesis. J Diabetes Res. 2015;2015:515307. https:\/\/doi.org\/10.1155\/2015\/515307.","journal-title":"J Diabetes Res"},{"key":"2560_CR7","doi-asserted-by":"publisher","first-page":"5235","DOI":"10.1074\/jbc.M111.327817","volume":"287","author":"S Bedrood","year":"2012","unstructured":"Bedrood S, Li Y, Isas JM, Hegde BG, Baxa U, Haworth IS, et al. Fibril structure of human islet amyloid polypeptide. J Biol Chem. 2012;287:5235\u201341. https:\/\/doi.org\/10.1074\/jbc.M111.327817.","journal-title":"J Biol Chem"},{"key":"2560_CR8","doi-asserted-by":"publisher","unstructured":"Hoffmann A, Caillon L, Salazar Vazquez LS, Spath P-A, Carlier L, Khemt\u00e9mourian L, et al. Time dependence of NMR observables reveals salient differences in the accumulation of early aggregated species between human islet amyloid polypeptide and amyloid-\u03b2. Phys Chem Chem Phys. 2018. https:\/\/doi.org\/10.1039\/C7CP07516B.","DOI":"10.1039\/C7CP07516B"},{"key":"2560_CR9","doi-asserted-by":"publisher","first-page":"e12977","DOI":"10.7554\/eLife.12977","volume":"5","author":"A Abedini","year":"2016","unstructured":"Abedini A, Plesner A, Cao P, Ridgway Z, Zhang J, Tu LH, et al. Time-resolved studies define the nature of toxic IAPP intermediates, providing insight for anti-amyloidosis therapeutics. Elife. 2016;5:e12977. https:\/\/doi.org\/10.7554\/eLife.12977.","journal-title":"Elife"},{"key":"2560_CR10","doi-asserted-by":"publisher","first-page":"15240","DOI":"10.1039\/C5RA27689F","volume":"6","author":"C-H Chen","year":"2016","unstructured":"Chen C-H, Yao T, Zhang Q, He Y-M, Xu L-H, Zheng M, et al. Influence of trehalose on human islet amyloid polypeptide fibrillation and aggregation. RSC Adv. 2016;6:15240\u20136. https:\/\/doi.org\/10.1039\/C5RA27689F.","journal-title":"RSC Adv"},{"key":"2560_CR11","doi-asserted-by":"publisher","first-page":"34156","DOI":"10.1074\/jbc.M102883200","volume":"276","author":"R Azriel","year":"2001","unstructured":"Azriel R, Gazit E. Analysis of the minimal amyloid-forming fragment of the islet amyloid polypeptide. An experimental support for the key role of the phenylalanine residue in amyloid formation. J Biol Chem. 2001;276:34156\u201361. https:\/\/doi.org\/10.1074\/jbc.M102883200.","journal-title":"J Biol Chem"},{"key":"2560_CR12","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jsb.2005.06.006","volume":"151","author":"R Khurana","year":"2005","unstructured":"Khurana R, Coleman C, Ionescu-Zanetti C, Carter SA, Krishna V, Grover RK, et al. Mechanism of thioflavin T binding to amyloid fibrils. J Struct Biol. 2005;151:229\u201338. https:\/\/doi.org\/10.1016\/j.jsb.2005.06.006.","journal-title":"J Struct Biol"},{"key":"2560_CR13","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1038\/s41598-017-02597-0","volume":"7","author":"EH Pilkington","year":"2017","unstructured":"Pilkington EH, Xing Y, Wang B, Kakinen A, Wang M, Davis TP, et al. Effects of protein Corona on IAPP amyloid aggregation, fibril remodelling, and cytotoxicity. Sci Rep. 2017;7:2455. https:\/\/doi.org\/10.1038\/s41598-017-02597-0.","journal-title":"Sci Rep"},{"key":"2560_CR14","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ab.2017.06.007","volume":"532","author":"M Sebastiao","year":"2017","unstructured":"Sebastiao M, Quittot N, Bourgault S. Thioflavin T fluorescence to analyse amyloid formation kinetics: measurement frequency as a factor explaining irreproducibility. Anal Biochem. 2017;532:83\u20136. https:\/\/doi.org\/10.1016\/j.ab.2017.06.007.","journal-title":"Anal Biochem"},{"key":"2560_CR15","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1021\/ja406831n","volume":"136","author":"LM Young","year":"2014","unstructured":"Young LM, Cao P, Raleigh DP, Ashcroft AE, Radford SE. Ion mobility spectrometry-mass spectrometry defines the oligomeric intermediates in amylin amyloid formation and the mode of action of inhibitors. J Am Chem Soc. 2014;136:660\u201370. https:\/\/doi.org\/10.1021\/ja406831n.","journal-title":"J Am Chem Soc"},{"key":"2560_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1139\/cjpp-2015-0117","volume":"94","author":"JS Fortin","year":"2016","unstructured":"Fortin JS, Benoit-Biancamano M-O. Inhibition of islet amyloid polypeptide aggregation and associated cytotoxicity by nonsteroidal anti-inflammatory drugs. Can J Physiol Pharmacol. 2016;94:35\u201348. https:\/\/doi.org\/10.1139\/cjpp-2015-0117.","journal-title":"Can J Physiol Pharmacol"},{"key":"2560_CR17","doi-asserted-by":"publisher","first-page":"e54198","DOI":"10.1371\/journal.pone.0054198","volume":"8","author":"H Gong","year":"2013","unstructured":"Gong H, Zhang X, Cheng B, Sun Y, Li C, Li T, et al. Bisphenol A accelerates toxic amyloid formation of human islet amyloid polypeptide: a possible link between bisphenol A exposure and type 2 diabetes. PLoS One. 2013;8:e54198. https:\/\/doi.org\/10.1371\/journal.pone.0054198.","journal-title":"PLoS One"},{"key":"2560_CR18","doi-asserted-by":"publisher","unstructured":"Bram Y, Frydman-Marom A, Yanai I, Gilead S, Shaltiel-Karyo R, Amdursky N, et al. Apoptosis induced by islet amyloid polypeptide soluble oligomers is neutralized by diabetes-associated specific antibodies. Sci Rep. 2014;4: SICI 4267. https:\/\/doi.org\/10.1038\/srep04267.","DOI":"10.1038\/srep04267"},{"key":"2560_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ijms.2015.09.001","volume":"391","author":"I Riba","year":"2015","unstructured":"Riba I, Barran PE, Cooper GJS, Unwin RD. On the structure of the copper-amylin complex. Int J Mass Spectrom. 2015;391:47\u201353. https:\/\/doi.org\/10.1016\/j.ijms.2015.09.001.","journal-title":"Int J Mass Spectrom"},{"key":"2560_CR20","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/J.BBRC.2012.02.042","volume":"419","author":"B Cheng","year":"2012","unstructured":"Cheng B, Gong H, Li X, Sun Y, Zhang X, Chen H, et al. Silibinin inhibits the toxic aggregation of human islet amyloid polypeptide. Biochem Biophys Res Commun. 2012;419:495\u20139. https:\/\/doi.org\/10.1016\/J.BBRC.2012.02.042.","journal-title":"Biochem Biophys Res Commun"},{"key":"2560_CR21","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1021\/jz5001775","volume":"5","author":"HR Patel","year":"2014","unstructured":"Patel HR, Pithadia AS, Brender JR, Fierke CA, Ramamoorthy A. In search of aggregation pathways of IAPP and other amyloidogenic proteins: finding answers through NMR spectroscopy. J Phys Chem Lett. 2014;5:1864\u201370. https:\/\/doi.org\/10.1021\/jz5001775.","journal-title":"J Phys Chem Lett"},{"key":"2560_CR22","doi-asserted-by":"publisher","unstructured":"Hoffmann A, Saravanan MS, Lequin O, Killian JA, Khemtemourian L. A single mutation on the human amyloid polypeptide modulates fibril growth and affects the mechanism of amyloid-induced membrane damage. Biochim Biophys Acta Biomembr. 2018. https:\/\/doi.org\/10.1016\/J.BBAMEM.2018.02.018.","DOI":"10.1016\/J.BBAMEM.2018.02.018"},{"key":"2560_CR23","doi-asserted-by":"publisher","first-page":"9829","DOI":"10.1021\/acs.analchem.5b02217","volume":"87","author":"H Li","year":"2015","unstructured":"Li H, Ha E, Donaldson RP, Jeremic AM, Vertes A. Rapid assessment of human amylin aggregation and its inhibition by copper(II) ions by laser ablation electrospray ionization mass spectrometry with ion mobility separation. Anal Chem. 2015;87:9829\u201337. https:\/\/doi.org\/10.1021\/acs.analchem.5b02217.","journal-title":"Anal Chem"},{"key":"2560_CR24","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nchem.2129","volume":"7","author":"LM Young","year":"2015","unstructured":"Young LM, Saunders JC, Mahood RA, Revill CH, Foster RJ, Tu LH, et al. Screening and classifying small-molecule inhibitors of amyloid formation using ion mobility spectrometry-mass spectrometry. Nat Chem. 2015;7:73\u201381. https:\/\/doi.org\/10.1038\/nchem.2129.","journal-title":"Nat Chem"},{"key":"2560_CR25","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ymeth.2015.05.017","volume":"95","author":"LM Young","year":"2016","unstructured":"Young LM, Saunders JC, Mahood RA, Revill CH, Foster RJ, Ashcroft AE, et al. ESI-IMS-MS: a method for rapid analysis of protein aggregation and its inhibition by small molecules. Methods. 2016;95:62\u20139. https:\/\/doi.org\/10.1016\/j.ymeth.2015.05.017.","journal-title":"Methods"},{"key":"2560_CR26","doi-asserted-by":"publisher","first-page":"7240","DOI":"10.1021\/ja1081537","volume":"133","author":"NF Dupuis","year":"2011","unstructured":"Dupuis NF, Wu C, Shea JE, Bowers MT. The amyloid formation mechanism in human IAPP: dimers have beta-strand monomer-monomer interfaces. J Am Chem Soc. 2011;133:7240\u20133. https:\/\/doi.org\/10.1021\/ja1081537.","journal-title":"J Am Chem Soc"},{"key":"2560_CR27","doi-asserted-by":"publisher","first-page":"8478","DOI":"10.1021\/bi300574r","volume":"51","author":"PJ Marek","year":"2012","unstructured":"Marek PJ, Patsalo V, Green DF, Raleigh DP. Ionic strength effects on amyloid formation by amylin are a complicated interplay among Debye screening, ion selectivity, and Hofmeister effects. Biochemistry. 2012;51:8478\u201390. https:\/\/doi.org\/10.1021\/bi300574r.","journal-title":"Biochemistry"},{"key":"2560_CR28","doi-asserted-by":"publisher","first-page":"8154","DOI":"10.1021\/bi3012548","volume":"51","author":"Y Suzuki","year":"2012","unstructured":"Suzuki Y, Brender JR, Hartman K, Ramamoorthy A, Marsh EN. Alternative pathways of human islet amyloid polypeptide aggregation distinguished by (19)f nuclear magnetic resonance-detected kinetics of monomer consumption. Biochemistry. 2012;51:8154\u201362. https:\/\/doi.org\/10.1021\/bi3012548.","journal-title":"Biochemistry"},{"key":"2560_CR29","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3233\/JAD-150147","volume":"47","author":"MY Suvorina","year":"2015","unstructured":"Suvorina MY, Selivanova OM, Grigorashvili EI, Nikulin AD, Marchenkov VV, Surin AK, et al. Studies of polymorphism of amyloid-\u03b2 42 peptide from different suppliers. J Alzheimers Dis. 2015;47:583\u201393. https:\/\/doi.org\/10.3233\/JAD-150147.","journal-title":"J Alzheimers Dis"},{"key":"2560_CR30","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.chroma.2008.10.051","volume":"1214","author":"R Verpillot","year":"2008","unstructured":"Verpillot R, Otto M, Klafki H, Taverna M. Simultaneous analysis by capillary electrophoresis of five amyloid peptides as potential biomarkers of Alzheimer\u2019s disease. J Chromatogr A. 2008;1214:157\u201364. https:\/\/doi.org\/10.1016\/j.chroma.2008.10.051.","journal-title":"J Chromatogr A"},{"key":"2560_CR31","doi-asserted-by":"publisher","unstructured":"Berardet C, Kaffy J, Ongeri S, Taverna M. A capillary electrophoresis method to investigate the oligomerization of the human islet amyloid polypeptide involved in type 2 diabetes. J Chromatogr A. 2018. https:\/\/doi.org\/10.1016\/j.chroma.2018.10.006.","DOI":"10.1016\/j.chroma.2018.10.006"},{"key":"2560_CR32","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ijms.2018.03.007","volume":"428","author":"K Richardson","year":"2018","unstructured":"Richardson K, Langridge D, Giles K. Fundamentals of travelling wave ion mobility revisited: I. Smoothly moving waves. Int J Mass Spectrom. 2018;428:71\u201380. https:\/\/doi.org\/10.1016\/j.ijms.2018.03.007.","journal-title":"Int J Mass Spectrom"},{"key":"2560_CR33","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s13361-016-1522-x","volume":"28","author":"G Van der Rest","year":"2017","unstructured":"Van der Rest G, Rezaei H, Halgand F. Monitoring conformational landscape of ovine prion protein monomer using ion mobility coupled to mass spectrometry. J Am Soc Mass Spectrom. 2017;28:303\u201314. https:\/\/doi.org\/10.1007\/s13361-016-1522-x.","journal-title":"J Am Soc Mass Spectrom"},{"key":"2560_CR34","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1007\/s13361-017-1810-0","volume":"28","author":"G Van der Rest","year":"2017","unstructured":"Van der Rest G, Halgand F. Size exclusion chromatography-ion mobility-mass spectrometry coupling: a step toward structural biology. J Am Soc Mass Spectrom. 2017;28:2519\u201322. https:\/\/doi.org\/10.1007\/s13361-017-1810-0.","journal-title":"J Am Soc Mass Spectrom"}],"container-title":["Analytical and Bioanalytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-020-02560-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00216-020-02560-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-020-02560-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T00:15:57Z","timestamp":1616544957000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00216-020-02560-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,24]]},"references-count":34,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["2560"],"URL":"https:\/\/doi.org\/10.1007\/s00216-020-02560-5","relation":{},"ISSN":["1618-2642","1618-2650"],"issn-type":[{"value":"1618-2642","type":"print"},{"value":"1618-2650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,24]]},"assertion":[{"value":"18 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}